Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Applying Real-World Device Data: US FDA Finalizes Its Thoughts

Executive Summary

The agency issued a final guidance spelling out reasonable applications of real-world device evidence and what factors must be considered when weighing whether data collected from routine care via means – such as electronic patient records or insurance claims – can help support a product approval or other regulatory decision.

Advertisement

Related Content

Real-World Evidence Requires 'Leap Of Faith' For Industry, FDA – Gottlieb
Leveraging mHealth Data For Product Development: FDA-Supported Action Plan Released
MDUFA IV (And More) Is Law: Trump Signs A Health-Care Bill
NEST Executive Director: A One Woman Army
Pilot Of New US Evaluation System Will Include At Least Two Devices
FDA Moves Real-World Evidence Paradigm Forward With Draft Guidance

Topics

Advertisement
UsernamePublicRestriction

Register

MT105389

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel